Which condition is a contraindication for HVLA due to bleeding risk?

Which condition is a contraindication for HVLA due to bleeding risk?

• A. Anticoagulants = Bleeding risk = Contraindication for HVLA
• B. Osteoporosis
• C. Hypertension
• D. Diabetes

Answer: (A)

Bleeding risk is the key consideration when evaluating HVLA. Anticoagulant therapy directly impairs the body's ability to clot, so a rapid joint thrust can lead to excessive bleeding or hematoma formation in the surrounding tissues. In areas like the spine or adjacent soft tissues, this can translate into serious complications such as spinal or retroperitoneal bleeding, making HVLA unsafe until medical clearance is obtained and the anticoagulation status is reassessed. The other conditions don’t carry the same direct bleeding-risk implication: osteoporosis raises fracture risk during manipulation, hypertension concerns the patient’s cardiovascular status during high-force maneuvers, and diabetes affects healing and other systemic factors but doesn’t inherently increase bleeding risk in the context of HVLA.

Bleeding risk is the key consideration when evaluating HVLA. Anticoagulant therapy directly impairs the body's ability to clot, so a rapid joint thrust can lead to excessive bleeding or hematoma formation in the surrounding tissues. In areas like the spine or adjacent soft tissues, this can translate into serious complications such as spinal or retroperitoneal bleeding, making HVLA unsafe until medical clearance is obtained and the anticoagulation status is reassessed.

The other conditions don’t carry the same direct bleeding-risk implication: osteoporosis raises fracture risk during manipulation, hypertension concerns the patient’s cardiovascular status during high-force maneuvers, and diabetes affects healing and other systemic factors but doesn’t inherently increase bleeding risk in the context of HVLA.